PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1351238
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1351238
Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential
The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.